Medical cannabis legalization and the use of illicit drugs, alcohol, and tobacco

Amidst the global shift toward cannabis legalization, this study examines medical cannabis (MC) sales as an indicator of economic activity and innovation. It explores associations between MC sales, and variables including tobacco use, alcohol consumption, amphetamine, cocaine and cannabis prevalence, and gross domestic product (GDP), using a fixed effects (FE) panel regression model. It also evaluates associations between cannabis legalization and MC sales over time using a dynamic Difference-in-Differences (DiD) approach with multiple time periods. METHODS: Panel data from 20 countries, including 14 with legalized medical cannabis and 6 without, are analyzed. The dynamic DiD approach estimates the average association for legalizing countries across multiple time periods, enabling comparisons of post-legalization outcomes with those of non-legalizing countries. RESULTS AND CONCLUSIONS: The findings indicate a strong negative association between tobacco use and MC sales, while cannabis consumption shows a positive association with MC markets. Amphetamine use is negatively associated with MC sales, suggesting substitution dynamics. Legalization is associated with an average annual increase of 26.06 tons of MC sales in legalizing countries. Event study estimates confirm a sustained growth trajectory in MC sales following legalization. A robustness check, which excludes the United States-a major outlier in market size-yields a slightly lower average effect of 20.05 but still supports the persistent market expansion. Given the ecological nature of the design, these results should be interpreted as population-level associations rather than individual-level causal effects. Nonetheless, they highlight the potential economic relevance of cannabis legalization in expanding regulated markets and reshaping consumer behavior. The study contributes to debates on legalization, public health, and economic policy by providing empirical evidence on the associations between legal reforms and market dynamics.

Authors

Institutions

Publication Details

Journal
Journal of Cannabis Research
Published
2025-09-09
DOI
https://doi.org/10.1186/s42238-025-00324-5
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medical cannabis legalization and the use of illicit drugs, alcohol, and tobacco

Hana Al Hallaj, Zahraa Barakat
Journal of Cannabis Research
Cannabis and Cannabinoid Research
article

Medical cannabis legalization and the use of illicit drugs, alcohol, and tobacco

Hana Al Hallaj, Zahraa Barakat
article en

Abstract

Amidst the global shift toward cannabis legalization, this study examines medical cannabis (MC) sales as an indicator of economic activity and innovation. It explores associations between MC sales, and variables including tobacco use, alcohol consumption, amphetamine, cocaine and cannabis prevalence, and gross domestic product (GDP), using a fixed effects (FE) panel regression model. It also evaluates associations between cannabis legalization and MC sales over time using a dynamic Difference-in-Differences (DiD) approach with multiple time periods. METHODS: Panel data from 20 countries, including 14 with legalized medical cannabis and 6 without, are analyzed. The dynamic DiD approach estimates the average association for legalizing countries across multiple time periods, enabling comparisons of post-legalization outcomes with those of non-legalizing countries. RESULTS AND CONCLUSIONS: The findings indicate a strong negative association between tobacco use and MC sales, while cannabis consumption shows a positive association with MC markets. Amphetamine use is negatively associated with MC sales, suggesting substitution dynamics. Legalization is associated with an average annual increase of 26.06 tons of MC sales in legalizing countries. Event study estimates confirm a sustained growth trajectory in MC sales following legalization. A robustness check, which excludes the United States-a major outlier in market size-yields a slightly lower average effect of 20.05 but still supports the persistent market expansion. Given the ecological nature of the design, these results should be interpreted as population-level associations rather than individual-level causal effects. Nonetheless, they highlight the potential economic relevance of cannabis legalization in expanding regulated markets and reshaping consumer behavior. The study contributes to debates on legalization, public health, and economic policy by providing empirical evidence on the associations between legal reforms and market dynamics.

Journal of Cannabis ResearchVol. 7(1)
Technische Universität Berlin (DE), Lebanese American University (LB)
Openalex Percentile: Top 73%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.